Who is sponsoring NCT03471312?

NCT03471312 is sponsored by Assiut University.

What drugs are being tested in NCT03471312?

Interventions in NCT03471312: Magnesium.

What condition does NCT03471312 study?

NCT03471312 studies Magnesium Therapy on Cerebral Palsy Patients.

Is NCT03471312 still recruiting?

NCT03471312 is currently status unknown. Last updated 20 March 2018.

Last reviewed 2018-03-20 · How we verify

NCT03471312

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Oral Magnesium Therapy on Constipation on Cerebral Palsy Children

Status unknown Last updated 20 March 2018

What this trial tests

trial testing Magnesium in Magnesium Therapy on Cerebral Palsy Patients in 50 participants. Status unknown.

Timeline

1 May 2018

Primary endpoint
30 October 2018

30 December 2018

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	50
Start date	1 May 2018
Primary completion	30 October 2018
Estimated completion	30 December 2018

Drugs / interventions tested

Magnesium — full drug profile →

Conditions studied

Magnesium Therapy on Cerebral Palsy Patients — all drugs for Magnesium Therapy on Cerebral Palsy Patients →

Sponsor

Assiut University

Who can join

Adults 1 Month to 18, any sex, with Magnesium Therapy on Cerebral Palsy Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to study the therapeutic and adverse effects of oral magnesium sulfate therapy on constipation in children with spastic cerebral palsy suffering from chronic constipation in neuro pediatric unit at Assiut University Hospital.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Magnesium

Trials testing the same drug.

NCT07502482 — The Effect of Magnesium on Post-spinal Headaches · not yet recruiting
NCT07309640 — The Effects of Magnesium (Mg) Supplement and Alternate Maxillary Expansion and Constriction (Alt-RAMEC) in Patient With · NA · not yet recruiting
NCT07082894 — Effect of Preoperative Oral Magnesium on Emergence Agitation · NA · completed
NCT07521358 — Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression · NA · completed
NCT07079514 — Effect of Magnesium Sulfate on Hemodynamics on Laparoscopic Cholecystectomy Patients · Phase 1, PHASE2 · completed

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03471312 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 20 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03471312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing